Impact of COVID-19 pandemic on anti-microbial resistance and secondary microbial infections
Open Access
- 25 February 2021
- journal article
- Published by Heighten Science Publications Corporation in International Journal of Clinical Virology
- Vol. 5 (1), 032-036
- https://doi.org/10.29328/journal.ijcv.1001032
Abstract
Corona Virus Disease-2019 (COVID-19) has become one of the most serious diseases in the history of mankind. It has captured the entire world and solutions are yet to be discovered to fight this global crisis. The outcomes of COVID-19 are influenced by a variety of pre-existing factors. The secondary microbial infections are one of the prominent ones that are major contributors for Antimicrobial Resistance (AMR) as they warrant the use of antimicrobial medications. The present review aimed at exploring the potential relationship between AMR under such circumstances and COVID-19 related outcomes. The published literature across the globe has delineated that the impact of COVID-19 may have worsened by a great degree due to the presence of secondary infections majorly bacterial ones. The consequences of COVID-19 have been fatal and a significant proportion can be a major attributor to AMR, either directly or indirectly. Although, there is a dearth of studies that can establish a very strong and direct relationship between AMR and negative COVID-19 outcomes so in-depth research on this topic is required to further explain this relationship in detail.Keywords
This publication has 33 references indexed in Scilit:
- Antibiotics, pregnancy, and fetal mental illnesses: where is the link?American Journal of Obstetrics and Gynecology, 2020
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- 2019 novel coronavirus (2019-nCoV) outbreak: A new challengeJournal of Global Antimicrobial Resistance, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Drug repurposing: progress, challenges and recommendationsNature Reviews Drug Discovery, 2018
- Macrolide and Azithromycin Use Are Linked to Increased Macrolide Resistance in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2006
- Ventilator-Associated Pneumonia: Diagnosis, Treatment, and PreventionClinical Microbiology Reviews, 2006
- Paradoxical Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rates Despite Barrier Precautions and Increased Hand Washing Compliance during an Outbreak of Severe Acute Repiratory SyndromeClinical Infectious Diseases, 2005
- Increase in Methicillin-Resistant Staphylococcus aureus Acquisition Rate and Change in Pathogen Pattern Associated with an Outbreak of Severe Acute Respiratory SyndromeClinical Infectious Diseases, 2004
- Is Azithromycin the First‐Choice Macrolide for Treatment of Community‐Acquired Pneumonia?Clinical Infectious Diseases, 2003